Other
Patient educational materials
Patient educational materials is an intervention with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
1(25%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
4
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(3)
Detailed Status
Completed3
Active, not recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A4 (100.0%)
Trials by Status
active_not_recruiting125%
completed375%
Recent Activity
1 active trials
Showing 4 of 4
active_not_recruitingnot_applicable
Collaborative Care for Polysubstance Use in Primary Care Settings (Co-Care)
NCT06116266
completednot_applicable
Comparison of Video-Based Versus Written Patient Education on Melanoma
NCT00826995
completednot_applicable
Comparison of Video-Based Versus Written Patient Education on Atopic Dermatitis
NCT00826592
completednot_applicable
Comparison Of Video-based Versus Written Patient Education on Sunscreen
NCT00826306
Clinical Trials (4)
Showing 4 of 4 trials
NCT06116266Not Applicable
Collaborative Care for Polysubstance Use in Primary Care Settings (Co-Care)
NCT00826995Not Applicable
Comparison of Video-Based Versus Written Patient Education on Melanoma
NCT00826592Not Applicable
Comparison of Video-Based Versus Written Patient Education on Atopic Dermatitis
NCT00826306Not Applicable
Comparison Of Video-based Versus Written Patient Education on Sunscreen
All 4 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 4